CClinicalTrials.gg
Not yet recruitingNCT07383831Updated Jul 28, 2026

Task-Shifting Adapted IPT-A for Youth Suicide Prevention

An interventional study of Adapted Brief Interpersonal Psychotherapy for Adolescents (IPT-A LAZOS) and Usual Community Center Services in Suicidal Ideation, Depressive Symptoms and Adolescent Mental Health, sponsored by Boston College. Not yet recruiting at 1 site in United States. Open to participants aged 12 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-07-28.

Sponsored by Boston College · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
12 Years to 17 Years
Sex
All
01

Study summary

The goal of this randomized pragmatic clinical trial is to examine the feasibility, acceptability, and mechanisms of change of a brief adaptation of Interpersonal Psychotherapy for Adolescents (BIPT-A), adapted and task-shifted to lay providers (mentors, youth trusted adults) in youth community centers (YCCs) as an upstream approach to suicide.

It focuses on Hispanic adolescents ages 12-17 enrolled in these YCCs. The pragmatic clinical trial will evaluate the acceptability and feasibility of adapted IPT-A delivered by mentors in YCCs and whether adapted BIPT-A impacts mechanisms of change (depressive symptoms, belongingness, and burdensomeness or feeling like a burden to others).

The main questions to answer are:

  • Is adapted BIPT-A, when delivered by trained lay providers (youth mentors), feasible and acceptable in youth community centers?
  • Does adapted BIPT-A, delivered by lay providers, change key risk factors (i.e., key mechanisms: depressive symptoms, low belongingness, and perceived burdensomeness) associated with suicide ideation? The investigators will compare adolescents randomized to adapted BIPT-A (6 sessions) delivered by a trained youth mentor with those receiving usual services at the community center (one individual session focused on active listening).

Participants will:

  1. Be screened for subthreshold depression using the Patient Health Questionnaire Adolescent version (PHQ-A). Adolescent participants will be included if they score between 4 and 9 (mild depression). Participants with a PHQ-A score of 10 or higher (severe depression) will not be eligible and will be referred to a licensed mental health provider for appropriate care.
  2. Be randomized to adapted BIPT-A or usual care. Adolescent participants in the intervention arm will participate in 6 weekly, adapted BIPT-A sessions with a trained youth mentor. Intervention focuses on education, affect identification, and interpersonal skills.
02

Conditions studied

  • Suicidal Ideation
  • Depressive Symptoms
  • Adolescent Mental Health
03

Who can participate

Ages eligible
12 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Parent consent
  2. Adolescent consent
  3. Enrolled in youth community centers
  4. Self-identified as Hispanic or Latine
  5. Between 12 and 17 years old.
  6. Scoring threshold for depression (4-9) as indicated in the PHQ-A.
  7. No current report of suicide ideation with plan or self-harming behaviors

Exclusion criteria

Exclusion Criteria:

  1. Not consented to participate in the study
  2. Scoring 10 or higher in the PHQ-A, indicating depressive disorder
  3. Active suicide ideation (i.e., having thoughts of killing oneself, thinking about how in the past month).
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    Adapted IPT-A Delivered by Youth Mentors

    Participants in this arm will receive 6 weekly sessions of an adapted, brief Interpersonal Psychotherapy for Adolescents (BIPT-A) delivered by trained youth mentors (n=5) at the partnering youth community centers. The intervention focuses on improving interpersonal functioning, communication skills, and supportive relationships to reduce depressive symptoms, low belongingness, and perceived burdensomeness.

    Behavioral: Adapted Brief Interpersonal Psychotherapy for Adolescents (IPT-A LAZOS)

  • Active comparator
    Usual Community Center Services

    Participants in this arm will continue to receive the standard youth programming and services offered at the participating community centers. This is an individual session focused on active listening.

    Other: Usual Community Center Services

Interventions

  • BehavioralAdapted Brief Interpersonal Psychotherapy for Adolescents (IPT-A LAZOS)

    Adolescents in this intervention will receive 6 weekly sessions of an adapted brief version of Interpersonal Psychotherapy for Adolescents (BIPT-A), delivered by trained lay providers (i.e., youth mentors) in youth community centers. The adaptation used a community-participatory research approach to culturally and contextually meet the needs of immigrant-origin inner-city adolescents. The adapted intervention keeps core elements (education, affect identification, and interpersonal skills) and bolsters these skills to target belongingness and burdensomeness, which are factors associated with suicide ideation. Sessions follow a structured, manualized approach. The goal is to reduce depressive symptoms, increase sense of belongingness, and decrease perceived burdensomeness among adolescents with subthreshold depression (score between 4-9 in the PHQ-A).

    Also known as: IPT-A, BIPT-A

  • OtherUsual Community Center Services

    Participants in this arm will continue to receive the standard youth programs and services offered by the youth community centers, including mentoring, academic support, and recreational activities. They will not receive BIPT-A.

    Also known as: Usual Care, Standard Youth Programming

05

What researchers measure

Primary outcomes

  1. Feasibility of the intervention

    The Feasibility of Intervention Measure (FIM) is a 4-item self-report survey (Weiner et al., 2017) used to assess whether the intervention can be successfully carried out (feasible). The scores for the 4 items are averaged, yielding a total score of 1-5, where 1-2 indicates low perceived feasibility, 3 indicates moderate, and 4-5 indicates high perceived feasibility. In summary, higher scores indicate higher perceived feasibility (a better outcome).

    Time frame: Up to 7 weeks.

  2. Acceptability of the intervention

    The Acceptability and Appropriateness of Intervention Measure (AIM) is an 8-item self-report survey that assesses whether the intervention is satisfactory (acceptability) and relevant (appropriateness). The measure is divided into 4-item subscales: acceptability and appropriateness. These constructs are evaluated separately, with an average score ranging from 1 (low) to 5 (high) (Weiner et al., 2017). Higher scores indicate higher satisfaction (acceptability) and relevance (appropriateness), meaning a better outcome.

    Time frame: Up to 7 weeks

Secondary outcomes

  1. Change in depressive symptoms

    Depressive symptoms are one of the study's mechanisms of change associated with passive suicide ideation. Depressive symptoms will be measured with the Patient Health Questionnaire-9 Adolescent version (PHQ-A), a 9-item self-report scale. PHQ-A has been validated with the adolescent and Hispanic populations. Most studies use ≥10 as the cutoff score, indicating clinically significant depressive symptoms among adolescents. The total score is the sum of all 9 items (0-27), where 0-4 is minimal or no depression, 5-9 mild depression, 10-14 moderate depression, 15-19 moderately severe depression, and 20-27 severe depression. In summary, higher scores indicate greater severity of depressive symptoms (a worse outcome).

    Time frame: Up to 7 weeks.

  2. Change in interpersonal factors associated with passive suicide ideation.

    Thwarted Belongingness (TB) and Perceived Burdensomeness (PB) are two factors associated with passive suicide ideation. These two factors are mechanisms of change targeted by the intervention. The Interpersonal Needs Assessment (INQ-15) measures the extent to which individuals believe they belong (i.e., TB using 9 items) or perceive themselves as a burden to others (i.e., PB using 6 items), which are scored separately, one for TB and one for PB. Scholars use either the sum score or the average. This study will use mean scores because they preserve the 1-7 scale and provide easier, consistent interpretation. Higher scores indicate higher Thwarted Belongingness and Perceived Burdensomeness (worse outcomes).

    Time frame: Up to 7 weeks.

Other outcomes

  1. Change in anxiety symptoms

    Due to the co-occurrence of depressive symptoms with anxiety among adolescents, the investigators will measure anxiety symptoms. The Generalized Anxiety Disorder (GAD-7), a 7-item self-report scale to assess anxiety, will be used to measure anxiety symptoms. A score of 10 or above typically indicates clinically significant anxiety symptoms and the need for further evaluation. The items (7) are summed, with scores ranging from 0 to 21, where 0-4 indicates minimal anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety. Higher scores indicate greater anxiety severity (a worse outcome).

    Time frame: Up to 7 weeks.

  2. Change in experiences with discrimination

    The Adolescent Discrimination Distress Index (ADDI; Fisher, Scyatta, \& Fenton, 2000) is a 15-item measure that assesses adolescent distress in response to perceived instances of racially motivated discrimination in institutional (e.g., stores, restaurants), educational (e.g., teacher evaluations), and peer contexts. It was developed to examine the nature and impact of racial and ethnic discrimination on development in multiethnic samples of youth. Students indicate whether they have experienced each type of discrimination because of their race or ethnicity and, if so, they rate how much it upset them, on a 5-point scale ranging from not at all to extremely. Total score range (15-75 using a sum). Higher scores indicate higher levels of distress (a worse outcome).

    Time frame: Up to 7 weeks.

06

Study locations

1 site
  • Boston College
    Chestnut Hill, Massachusetts 02467, United States
    • Carolina Vélez-Grau, PhD, LCSW · Contact · velezgra@bc.edu · 6175522539
    • · Contact · velezgra@bc.edu
    • Carolina Vélez-Grau, PHD, LCSW · Principal investigator
07

References and documents

Individual participant data

Plan to share: Yes — The National Institute of Mental Health (NIMH) Data Archive (NDA) will be used. NDA is an NIH-funded collaborative resource that contains harmonized human subjects research data. Data submitted to the NDA is stripped of identifiers.

Supporting information: Analytic code

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07383831
Lead sponsor
Boston College
Responsible party
Sponsor
First posted
Feb 3, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Dec 1, 2027 (estimated)
Completion
Jul 31, 2028 (estimated)
Last update
Jul 28, 2026

Study contacts

Carolina Vélez-Grau, PhD and LCSW
Contact
velezgra@bc.edu
16175522539
Krystel Francis, BA
Contact
francik@bc.edu
Carolina Vélez-Grau, PHD, LCSW
principal investigator · Boston College
Laura Mufson, PhD
study chair · Columbia University
Susan Witte, PhD
study chair · Columbia University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion